Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 0 | 14 | 8 |
| Cost of Goods | N/A | N/A | N/A | 12 | 2 |
| Gross Profit | N/A | N/A | N/A | 2 | 6 |
| Operating Expenses | 2,386 | 2,330 | 2,212 | 3,086 | 2,869 |
| Operating Income | -2,386 | -2,330 | -2,212 | -3,068 | -2,865 |
| Other Income | 36 | 5 | 22 | -13 | -8 |
| Pre-tax Income | -2,350 | -2,325 | -2,190 | -3,081 | -2,873 |
| Income Tax | 29 | N/A | N/A | -46 | 194 |
| Net Income Continuous | -2,379 | -2,325 | -2,190 | -3,035 | -3,067 |
| Net Income | $-2,379 | $-2,325 | $-2,190 | $-3,035 | $-3,067 |
| EPS Basic Total Ops | -0.08 | -0.08 | -0.08 | -0.10 | -0.11 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.08 | -0.11 | -0.11 |
| EPS Diluted Total Ops | -0.08 | -0.08 | -0.08 | -0.10 | -0.11 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.08 | -0.11 | -0.11 |
| EBITDA(a) | $-2,372 | $-2,315 | $-2,198 | $-3,056 | $-2,845 |